Indaptus Therapeutics Files Prospectus Related To The Resale By The Selling Stockholders Of Up To 18.86M Shares Of Common Stock

Benzinga Newsdesk www.benzinga.com Neutral 93.3%

Neg 0% Neu 93.3% Pos 0%

https://www.sec.gov/Archives/edgar/data/1857044/000149315226030346/forms-3.htm

Comments

No comments yet. Be the first!